pargyline has been researched along with Psychoses, Drug in 4 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
SUTNICK, AI | 1 |
WEISS, LB | 1 |
SCHINDLER, PD | 1 |
SOLOFF, LA | 1 |
MCCURDY, RL | 1 |
KAN, FJ | 1 |
Shopsin, B | 1 |
Kline, NS | 1 |
Price, J | 1 |
Hopkinson, G | 1 |
1 review available for pargyline and Psychoses, Drug
Article | Year |
---|---|
Mono-amine oxidase inhibitors and schizophrenia.
Topics: Acute Disease; Amines; Amphetamine; Chronic Disease; Hallucinogens; Humans; Iproniazid; Isoniazid; M | 1968 |
3 other studies available for pargyline and Psychoses, Drug
Article | Year |
---|---|
PSYCHOTIC REACTIONS DURING THERAPY WITH PARGYLINE.
Topics: Aged; Antihypertensive Agents; Geriatrics; Humans; Hypotension; Hypotension, Orthostatic; Monoamine | 1964 |
TRANSIENT BRAIN SYNDROME AS A NON-FATAL REACTION TO COMBINED PARGYLINE-IMIPRAMINE TREATMENT.
Topics: Brain; Depression; Depressive Disorder; Drug Therapy; Geriatrics; Hypertension; Imipramine; Mental D | 1964 |
Monoamine oxidase inhibitors: potential for drug abuse.
Topics: Amphetamines; Drug Tolerance; Feeding Behavior; Humans; Imipramine; Male; Middle Aged; Monoamine Oxi | 1976 |